Spectrum Pharmaceuticals, Inc.

NasdaqCM:SPPI Voorraadrapport

Marktkapitalisatie: US$209.9m

Spectrum Pharmaceuticals Balans Gezondheid

Financiële gezondheid criteriumcontroles 3/6

Spectrum Pharmaceuticals heeft een totaal eigen vermogen van $26.8M en een totale schuld van $28.8M, wat de schuld-eigenvermogensverhouding op 107.6% brengt. De totale activa en totale passiva bedragen respectievelijk $107.7M en $80.9M.

Belangrijke informatie

107.6%

Verhouding schuld/eigen vermogen

US$28.84m

Schuld

Rente dekkingsration/a
ContantUS$56.14m
AandelenUS$26.81m
Totaal verplichtingenUS$80.87m
Totaal activaUS$107.68m

Recente financiële gezondheidsupdates

Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?

Sep 16
Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?

Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Jun 04
Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Recent updates

Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts

May 14
Analysts Just Made A Huge Upgrade To Their Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Forecasts

Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Boosting Their Estimates

May 12
Earnings Update: Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Just Reported And Analysts Are Boosting Their Estimates

Spectrum plunges 28% after FDA scientists question poziotinib evidence for NSCLC

Sep 20

Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?

Sep 16
Is Spectrum Pharmaceuticals (NASDAQ:SPPI) In A Good Position To Invest In Growth?

Spectrum Pharmaceuticals stock jumps 10% afterhours on FDA nod for Rolvedon injection

Sep 09

Spectrum Pharmaceuticals: Revisiting This 'Soap Opera'

Aug 21

Spectrum Pharmaceuticals Q2 2022 Earnings Preview

Aug 10

Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Jun 04
Here's Why We're A Bit Worried About Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Spectrum Pharmaceuticals: Some Last Words

Feb 25

Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Oct 05
Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

Spectrum Pharmaceuticals' CRL: There Is Very Little Clarity

Aug 12

Spectrum's Big Approval: Any Day Now

Jul 29

FDA initiates pre-approval inspection for Spectrum pharmaceuticals' ROLONTIS

Jun 01

Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

May 31
Here's Why We're Watching Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Situation

We're Keeping An Eye On Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate

Feb 12
We're Keeping An Eye On Spectrum Pharmaceuticals' (NASDAQ:SPPI) Cash Burn Rate

Spectrum Pharma drops after announcing less-than-favorable Phase 2 data

Dec 22

Here's What Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Shareholder Ownership Structure Looks Like

Dec 21
Here's What Spectrum Pharmaceuticals, Inc.'s (NASDAQ:SPPI) Shareholder Ownership Structure Looks Like

Spectrum Pharma Is Down But Not Out

Nov 16

Spectrum Shareholders In Limbo As FDA Delays Rolontis Decision Date, Agrees To Discuss Poziotinib

Nov 11

Analyse van de financiële positie

Kortlopende schulden: De korte termijn activa ( $105.4M ) SPPI } overtreffen de korte termijn passiva ( $38.9M ).

Langlopende schulden: De kortetermijnactiva SPPI ( $105.4M ) overtreffen de langetermijnschulden ( $42.0M ).


Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: SPPI heeft meer geld in kas dan de totale schuld.

Schuld verminderen: De schuld/eigen vermogen-ratio van SPPI is de afgelopen 5 jaar gestegen van 12% naar 107.6%.


Balans


Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: SPPI heeft minder dan een jaar aan cash runway op basis van de huidige vrije kasstroom.

Voorspelling contante baan: Er zijn onvoldoende gegevens om te bepalen of SPPI voldoende cash runway heeft als de vrije kasstroom blijft groeien of krimpen op basis van historische percentages.


Ontdek gezonde bedrijven